Business Context and Reporting Period
Company: Compugen Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Second Quarter 2016 (Six months ended June 30, 2016)
Filing Date: August 9, 2016
This filing serves as a cover document incorporating the Company's unaudited interim consolidated financial statements and Operating and Financial Review and Prospects by reference. The primary financial data is contained in Exhibits 99.1 and 99.2, which are not included in the text of this Form 6-K.
Key Financial Metrics
The text of this Form 6-K does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the incorporated exhibits (Exhibit 99.1 and 99.2) referenced in the filing.
Material Changes
The filing references a comparison between the six months ended June 30, 2016, and the same period in 2015. However, the specific material changes in financial performance or operations are detailed in the incorporated Operating and Financial Review (Exhibit 99.2) and are not present in the cover text.
Guidance, Outlook, and Risks
Outlook: Management commentary and prospects are included in Exhibit 99.2, which is incorporated by reference but not reproduced in this text.
Risks and Contingencies: No specific risks or contingencies are detailed in the cover text. The filing notes that confidential treatment has been requested for certain portions of the Research and Development Collaboration and License Agreement amendments with Bayer Pharma AG (Exhibits 10.1, 10.2, and 10.3).
Important Facts for Investor Verification
- Verify the specific financial results (revenue, net loss, cash position) by reviewing Exhibit 99.1 (Unaudited interim consolidated financial statements).
- Review Exhibit 99.2 for the detailed Operating and Financial Review and Prospects to understand management's outlook.
- Note that portions of the collaboration agreements with Bayer Pharma AG (Exhibits 10.1, 10.2, 10.3) have been redacted for confidential treatment.
- Confirm the incorporation of this Form 6-K into the Company's Registration Statement on Form F-3 (File No. 333-198368).